Evidence map›Paper›PMID 31836766›Full record

ArticleScientific reports2019

Converging TLR9 and PI3Kgamma signaling induces sterile inflammation and organ damage.

Braulio Henrique Freire Lima, Pedro Elias Marques, Lindisley Ferreira Gomides, Matheus Silvério Mattos, Lucas Kraemer, Celso M Queiroz-Junior, Mark Lennon, Emilio Hirsch, Remo Castro Russo, Gustavo Batista Menezes and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. [Mechanism and material basis ofNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Braulio Henrique Freire LimaDepartment of Biochemistry and Immunology, Institute of Biological Sciences, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0003-1226-1665
Pedro Elias MarquesDepartment of Biochemistry and Immunology, Institute of Biological Sciences, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-5613-8012
Lindisley Ferreira GomidesCenter for Gastrointestinal Biology, Instituto de Ciências Biológicas, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Matheus Silvério MattosPhysiology and Biophysics/Instituto de Ciencias Biologicas, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-9163-6279
Lucas KraemerPhysiology and Biophysics/Instituto de Ciencias Biologicas, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Celso M Queiroz-JuniorDepartament of Morphology, Institute of Biological Sciences, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-7884-7709
Mark LennonTarget Sciences, GlaxoSmithKline, Stevenage, Hertfordshire, Stevenage, United Kingdom.
Emilio HirschDepartment ot Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.ORCID http://orcid.org/0000-0002-9073-6024
Remo Castro RussoPhysiology and Biophysics/Instituto de Ciencias Biologicas, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-1715-3834
Gustavo Batista MenezesCenter for Gastrointestinal Biology, Instituto de Ciências Biológicas, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Edith M HesselRefractory Respiratory Inflammation DPU, GlaxoSmithKline, Hertfordshire, Stevenage, United Kingdom.ORCID http://orcid.org/0000-0002-2339-4482
Augustin AmourRefractory Respiratory Inflammation DPU, GlaxoSmithKline, Hertfordshire, Stevenage, United Kingdom.ORCID http://orcid.org/0000-0002-7369-415X
Mauro Martins TeixeiraDepartment of Biochemistry and Immunology, Institute of Biological Sciences, Feredal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. mmtex.ufmg@gmail.com.ORCID http://orcid.org/0000-0002-6944-3008
Universidade Federal de Minas Gerais · BRGlaxoSmithKline (United Kingdom) · GBUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptor 9 (TLR9) and Phosphatidylinositol-3-kinase gamma (PI3Kγ) are very important effectors of the immune response, however, the importance of such crosstalk for disease development is still a matter of discussion. Here we show that PI3Kγ is required for immune responses in which TLR9 is a relevant trigger. We demonstrate the requirement of PI3Kγ for TLR9-induced inflammation in a model of CpG-induced pleurisy. Such requirement was further observed in inflammatory models where DNA sensing via TLR9 contributes to disease, such as silicosis and drug-induced liver injury. Using adoptive transfer, we demonstrate that PI3Kγ is important not only in leukocytes but also in parenchymal cells for the progression of inflammation. We demonstrate this crosstalk between TLR9 and PI3Kγ in vitro using human PBMCs. The inhibition of PI3Kγ in CpG-stimulated PBMCs resulted in reduction of both cytokine production and phosphorylated Akt. Therefore, drugs that target PI3Kγ have the potential to treat diseases mediated by excessive TLR9 signalling.

Indexed as

Organ SpecificitySignal TransductionAnimalsCell SurvivalClass Ib Phosphatidylinositol 3-KinaseCytokinesFemaleGene DeletionInflammationLiverLungMice, Inbred C57BLOligodeoxyribonucleotidesPleuraPulmonary FibrosisQuinoxalines5-quinoxalin-6-ylmethylenethiazolidine-2,4-dioneClass Ib Phosphatidylinositol 3-KinaseCPG-oligonucleotideCytokinesOligodeoxyribonucleotidesPik3cg protein, mouseQuinoxalinesSilicon DioxideThiazolidinedionesToll-Like Receptor 9

Identifiers

PMID31836766
PMCPMC6910931
OpenAlexW2996474595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.